Clinical trial
A Comparison of Safety and Inhalation Times of Ventavis (Iloprost) Inhalation Solution Delivered by I-Neb Utilizing Power Disc-6 and Power Disc-15 "Power 15 Study"
NCT00467896 is registered in ClinicalTrials.gov with Actelion as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Comparison of Safety and Inhalation Times of Ventavis (Iloprost) Inhalation Solution Delivered by I-Neb Utilizing Power Disc-6 and Power Disc-15 "Power 15 Study"
- Lead sponsor
- Actelion
- Phase
- Phase 2
- Overall status
- Terminated
- Start date
- September 30, 2006
- Completion date
- June 30, 2011
- Enrollment
- 62 (actual)
- Sites
- 12
Conditions
As the registry lists them; a condition with its own page is linked.
pulmonary hypertension